Purdue Pharma agrees $12bn settlement in opioids case, plaintiffs’ lawyers say

Offer by company and Sackler family valued at up to $12bn, with company to fight opponents of deal in bankruptcy proceedings Purdue Pharma, the maker of OxyContin, has reached a tentative deal with about half the states and thousands of local governments over its role in Americas deadly opioid epidemic, but criticism by several state attorneys general clouded prospects for an end to litigation against the company and the family that owns it. Arizona attorney general Mark Brnovich said the agreement included more money from the Sackler family, which had become a sticking point during the recent talks. Talks are progressing rapidly, but this is the quickest and surest way to get immediate relief for Arizona and for the communities …

OxyContin maker filing for bankruptcy may shed light on wrongdoings

Purdue Pharma may be forced to file after talks broke down over settlement, allowing public to learn what really happened A leading addiction specialist has welcomed an anticipated decision by OxyContin maker Purdue Pharma to file for bankruptcy after settlement talks over the nations deadly overdose crisis broke down over the weekend. No deal is better than a bad deal, said Dr Andrew Kolodny, founder and executive director of Physicians for Responsible Opioid Prescribing. Kolodny, a longtime critic of opioid prescribing, said the proposed settlement would have left Purdue Pharma profiting from future sales of the drug that is widely held responsible for creating an opioid epidemic that has cost 400,000 American lives over the past two decades. Kolodny recently …

Drug maker ‘will make $21bn from treating cystic fibrosis’

Vertex is accused of raking in vast profits while making Orkambi unaffordable to NHS A US company, which is refusing to drop its price for the life-changing cystic fibrosis drug Orkambi to make it affordable to NHS England, is set to make $21bn (17bn) in profit from that and a sister medicine, according to research. Countries around the world are struggling to pay for Orkambi, made by Vertex, which has a list price of 104,000 per patient per year and is not a cure. The National Institute of Health and Care Excellence (Nice) in England has said effective. On Monday, the Scottish Medicines Consortium will decide whether to approve the drug for children. Parents in England have campaigned, demonstrated on …

The controversial ketamine-like drug that Trump is pushing on veterans

The president has touted the drugs benefits and offered to help a senior VA official negotiate the purchase of the drug Personal interest from Donald Trump appears to have put a controversial anti-depressant on a fast track at the Department of Veterans Affairs (VA) that shoved aside usual protocols, even though experts inside and outside the government have serious concerns the drug is effective and say it may be dangerous. Sources inside the Department of Veterans Affairs say staffers were essentially told by a senior official to drop everything in March and accelerate the drugs availability because the president had expressed enthusiasm for the drug, Spravato, as a possible treatment for depressed veterans. Questions have also been raised about a …

Purdue Pharma agrees to settle OxyContin opioid case with Oklahoma

Purdue and the Sacklers to pay Oklahoma $270m in settlement over aggressive and illegal marketing of painkiller Members of the opioid epidemic, appear for the first time to have acknowledged a role in the public health crisis that overall has claimed more than 350,000 lives over the past two decades. The settlement does not reflect any admission of wrongdoing by the Sacklers. Oklahomas attorney general, Mike Hunter, called the settlement a monumental victory and a new day in battle against opioid epidemic. sued personally by more than 500 cities, counties and Native American tribes in a massive lawsuit in New York federal court last week. Paul Hanly, a US lawyer heading a different federal lawsuit, which is consolidating about 1,600 …